TransMedics Group (TMDX) PT Raised to $170 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Matt O'Brien raised the price target on TransMedics Group (NASDAQ: TMDX) to $170.00 (from $120.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
